Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine if fluorescence angiography can detect occult shock (hypoperfusion).


Clinical Trial Description

Hypoperfusion may be multifactorial, due to hemorrhage, shock or other disease processes resulting in either capillary leak into the interstitium or profound vasodilatation. Currently, diagnosis of hypoperfusion depends on indirect markers of perfusion such as lactate, blood pressure, creatinine, urine output, and mental status. These are all late signs of hypoperfusion as they are precursors to impending system failure. In this study, the focus will be on one of the most common causes of hypoperfusion in the surgical population; sepsis and septic shock. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02846727
Study type Observational
Source Yale University
Contact
Status Withdrawn
Phase N/A
Start date August 2016
Completion date September 2018

See also
  Status Clinical Trial Phase
Recruiting NCT04166331 - Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion Phase 3
Recruiting NCT05582824 - Lactate Metabolism in the Hypoperfused Critically Ill
Terminated NCT04538079 - Non-invasive Objective Assessment of Hemodynamics in Preterm Neonates
Terminated NCT05499624 - POMCO2 Clinical Study MicroTrend System pCO2 Sensor N/A
Completed NCT05145049 - The Relationship of Anesthesia Method With Serum Lactate Level in Craniotomies
Terminated NCT04198168 - The Predictive Performance of Renal Ultrasound on Changes in Renal Clearance
Not yet recruiting NCT01272843 - Physiological Magnetic Resonance Imaging (MRI) to Improve Carotid Endarterectomy Outcomes N/A
Not yet recruiting NCT05953142 - Use of Dobutamine in Patients With Sepsis and Maintained Hypoperfusion After Initial Volemic Resuscitation. Phase 2
Enrolling by invitation NCT01239303 - Effects of Citrulline on Gut Functioning During Excercise N/A